Arterial Capital Management

Arterial Capital Management is a private equity firm focused exclusively on the global life science sector. We specialise in providing equity funding to biotech, medtech or pharmaceutical companies. Our investment approach is to fund well-researched, innovative projects, with proven management teams, recognised trial data, strong IP and a demonstrable opportunity for significant commercial upside. We target investee firms with strong corporate governance and the potential to return 5-25 times the gross investment within a three to five year timescale. In the current environment, many companies seeking capital for medical trials have encountered a dwindling supply of funding from governments, private equity firms, investment banks and research foundations. At Arterial, our unique approach, coupled with the global reputation of our advisory team, enables us to select the best investment opportunities available. We believe this is attributable to both our specialist world class team and their proven track record in the life science sector, plus the strong emphasis we place upon ensuring our investments are attractive to both high net worth private clients and larger corporates, through their professional advisers. For our business to be truly successful, we fully understand the need to look after all parties, including our investees, investors and professional advisers throughout the life of the investment. Our financial success is directly related to the financial return of all parties and we never forget that we all share a common goal.